PREMATURE RUPTURE OF MEMBRANES AT TERM: REVIEW ON MANAGEMENT
Keywords:
mísoprostol, oxytocin, premature rupture of membranes, labor obstetrícAbstract
Premature rupture of membranes at term is a frequent condition in obstetric practice, but to this day there is controversy regarding the best management of this condition. This review presents a brief historical overview and a/so approaches etiologic factors involved in this condition. lts purpose ís to present possible management schedules for premature rupture of the membranes at term, reporting on obstetríc and perínatal outcomes assocíated wíth methods for labor índuction, includíng the use of prostaglandin, oxytocín or expectant management. Accordíng to data avaílable ín the scientífic líterature, the ímmedíate índuction of labor with misoprostol may reduce the rate of cesarean sectíon and maternal and neonatal ínfectíon. There is enough scientífic evídence to recommend thís practice for pregnant women with premature rupture of membranes at term.
Downloads
References
Duff P. Premature rupture of membranes in term patients: induction of labor versus expectant management. Clin Obstet Gynecol. 1998; 41(4):883-91.
Tan BP, Hannah ME. Prostaglandins versus oxytocin for prelabour rupture of membranes at or near term. Cochrane Database Syst Rev. 2000; (2):CD000159. Review.
Kovavisarach E, Sermsak P. Risk factors related to premature rupture of membranes in the pregnant women: a case-contrai study. Aust N Z J Obstet Gynaecol. 2000; 49(1):30-2.
Ladfors L, Mattsson LA, Eriksson M, Milson 1. Prevalence and risk factors for prelabor rupture of the membranes (PROM) at or near-term in an urban Swedish population. J Perinat Med. 2000; 28(6):491-6
Canova 1, Caputo S, Ciardo A, Stragapede B. Bacterial vaginosis and pregnancy. Clin Ter. 2002; 1 53(5):343-6.
Garite TJ. Premature rupture of membranes: The enigma of the obstetrician. Am J Obstet Gynecol. 1985; 151(8):1001-6.
Lanier LR, Scarbrough RW, Fillingim DW, Baker RE. lncidence of maternal and fetal complications associated with rupture of the membranes before onset of labor. Am J Obstet Gynecol. 1965; 93:398-404.
Mozurkewich E. Management of premature rupture of membranes at term: an evidence-based approach. Clin Obstet Gynecol. 1999; 42(4):749-56.
Hauth JC, Cunningham G, Whalley PG. Early labor initiation with oral PG E2 after premature rupture of the membrans at term. Obstet Gynecol. 1976; 49:523-26.
Kappy KA, Cetrulo CL, Knuppel RA, lngardia CJ, Sbarra AJ, Scerbo JC, et ai. Premature rupture of the membranes at term: a conservative approach. Am J Obstet Gynecol. 1979; 134(6):655-61.
Schutte MF, Treffers PE, Kloosterman GJ, Soepatmi S. Management of premature rupture of membranes: The risk of vaginal examination to the infant. Am J Obstet Gynecol. 1983; 146(4):395-400.
Morales WJ, Lazar AJ. Expectant management of rupture of membranes at term. South Med J. 1986; 79(8):955-8.
Rydstrõm H, Arulkumaram S, lngemarsson 1, Jothi Kumar K, Ratnam SS. Premature rupture of membranes at term. Acta Obstet Gynecol Scand. 1996; 65(4):587-91.
Conway DL, Prendiville WJ, Morris A, Speller DCE, Stirrat GM. Management of spontaneous rupture of the membranes in the absence of labor in primigravid women at term. Am J Obstet Gynecol. 1984; 150(8):947-51.
Wagner M, Chin V, Peters CJ, Drexler B, Newman LA. A comparison of early and delayed induction of labor with spontaneous rupture of membranes at term. Obstet Gynecol. 1989; 74(1):93-7.
Ekman-Ordeberg G, Uldbjerg N, Ulmsten U. Comparison of intravenous oxytocin and vaginal prostaglandin E2 gel in women with unripe cervixes and premature rupture of the membranes. Obstet Gynecol. 1985; 66(3):307-1O.
Yoder PR, Gibbs RS, Blanco JD, Castaneda Y, Clair PJ. A prospective, controlled study of maternal and perinatal outcome after intra-amniotic infection at term. Am J Obstet Gynecol. 1983; 145(6):695-701.
Grant JM, Serie E, Mahmood T, Sarmandal P, Conway DY. Management of prelabour rupture of the membranes in term primigravidae: report of a randomized prospective triai. Br J Obstet Gynaecol. 1992; 99(7):557-62.
Hjertberg R, Hammarstrom M, Moberger B, Nordlander E, Granstrom L. Premature rupture of membranes (PROM) at term in nulliparous women with a ripe cervix. A randomized triai of 12 or 24 hours of expectant management. Acta Obstet Gynecol Scand. 1996; 75(1):48-53.
Ottervanger HP, Keirse MJ, Smith W, Holm JP. Controlled comparison of induction versus expectant care for prelabor rupture of membranes at term. J Perinat Med. 1996; 24(3):237-42.
Tedesco RP, Maia Filho NL, Cecatti JG, Andreoni R. Comparação entre Conduta Ativa com Ocitocina e Conduta Expectante na Rotura prematura de Membranas em Gestações a Termo. Rev Braz Gynecol Obstet. 1998; 20(9):495-501.
Natale R, Milne JK, Campbel MK, Potts PG, Webster K, Halinda E. Management of premature rupture of membranes at term: randomized triai. Am J Obstet Gynecol. 1994; 171(4):396-9.
Hallak M, Bottoms SF. lnduction of labor in patients with term premature rupture of membranes. Effect on perinatal outcome. Fetal Diagn Ther. 1999; 14(3):138-42.
Watson WJ, Stevens D, Welter S, Day D. Factors predicting successful labor induction.. Obstet Gynecol. 1996; 88(6):990-2.
Egan D, O'Herlihy C. Expectant management of spontaneous rupture of membranes at term. Br J Obstet Gynaecol. 1988; 8:243.
Seaward PG, Hannah ME, Myhr TL, Farine D, Ohlsson A, Wang EE, et_ ai. lnternational multicenter term PROM study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of the membranes at term. Premature Rupture of Membranes. Am J Obstet Gynecol. 1998; 179(3Pt1):635-9.
Johnson JW, Daikoku NH, Niebyl JR, Jonhson TR Jr, Khouzami VA, Witter FR. Premature rupture of the membranes and prolonged latency. Obstet Gynecol. 1981; 57(5):547-56.
Ray D, Garite T. Prostaglandin E2 for induction of labor in patients with premature rupture of membranes at term. Am J Obstet Gynecol. 1992; 166(3):836-43.
Mozurkewich EL, Wolf FM. Premature rupture of membranes at term a meta-analysis of three management schemes. Obstet Gynecol. 1997; 89(6):1035-43.
Hannah ME, Ohlsson A, Farine D, Hewson SA, Hodnett ED, Myhr TL, et ai. lnduction of labor compareci with expectant management for prelabor rupture of the membranes at term. TERMPROM Study Group. N Engl J Med. 1996; 334(16):1005-10.
Tan BP, Hannah ME. Prostaglandins versus oxytocin for prelabour rupture of membranes ator near term. Cochrane Database Syst Rev. 2000; (2):CD000178.
Gafni A, Goeree R, Myhr TL, Hannah ME, Blackhouse G, Willan AR, et ai. lnduction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation TERMPROM Study Group. Term Prelabour Rupture of Membranes. CMAJ. 1997; 157(11):1519-25.
Bugalho A, Bique C, Machungo F, Faúndes A. lnduction of labor with intravaginal misoprostol in intrauterine fetal death. Am J Obstet Gynecol. 1994; 171(2):538-41.
Surita FGC, Cecatti JG, Parpinelli MA, Silva JLP. Misoprostol versus laminaria for cervical ripening in pregnancies with fetal death. Rev Ciênc Méd. 2002; 11(1):11-8.
Margoulies MP, Voto S. Misoprostol to induce labor [Letter]. Lancet. 1992; 339:64.
Wing DA, Jones MM, Rahall A, Goodwin TM, Paul RH. A comparison of misoprostol and prostagladin E2 gel for preinduction cervical ripening and labor induction. Am J Obstet Gynecol. 1995; 172(6): 1804-10.
Wing DA, Rahall A, Jones MM, Goodwin TM, Paul RH. Misoprostol: an effective agent for cervical ripening and labor induction. Am J Obstet Gynecol. 1995; 172(6):1811-6.
American College of Obstetricians and Gynecologists. Committee Opinion - lnduction of labor with misoprostol. lnt J Gynecol Obstet. 2000; 69:77-8.
Aquino MMA, Cecatti JG. Misoprostol. versus oxytocin for labor induction in term and post term pregnancy: Randomized controlled triai. São Paulo Medical J. 2003; 121(3):102-6.
Sanchez-Ramos L, Chen AH, Kaunitz AM, Gaudier FL, Delke 1. Labor induction with intravaginal misoprostol in term premature rupture of membranes: a randomized study. Obstet Gynecol. 1997; 89(6):
-12.
Ngai SW, Chan YM, Lam SW, Lao TT. Labour characteristics and uterine activity: misoprostol compareci with oxytocin in women at term with prelabour rupture of the membranes. BJOG. 2000; 107(2):222-7.
Hoffmann RA, Anthony J, Fawcus S. Oral misoprostol vs placebo in the management of prelabor rupture of membranes at term. lnt J Gynaecol Obstet. 2001; 72(3):21 5-21.
Ozden S, Delikara MN, Avci A, Ficicioglu C. lntravaginal misoprostol vs. expectant management in premature rupture of membranes with low Bishop scores at term. lnt J Gynaecol Obstet. 2002; 77(2):109-15
Tedesco RP, Cecatti JG, Maia Filho NL. Efetividade de Duas Diferentes doses de Misoprostol por Via Vaginal para Preparo Cervical e Indução do Parto. Rev Bras Ginecol Obstet. 2002; 24(10):641-6.
